Royal Bank of Canada’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-24,000
Closed -$4.93M – 7159
2025
Q4
$4.93M Buy
+24,000
New +$4.52M ﹤0.01% 2438
2022
Q1
– Sell
-9,000
Closed -$463K – 7752
2021
Q4
$463K Buy
+9,000
New +$441K ﹤0.01% 4532

Other funds holding CAH

Royal Bank of Canada's CAH Position: Q2 2026 in Review

Royal Bank of Canada reduced its Cardinal Health (CAH) stake by 18% in Q2 2026, selling an estimated $35.7M and leaving 780,931 shares worth $186M. The position accounts for 0.03% of the portfolio, ranked #475.

Royal Bank of Canada first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. The position peaked at $201M in Q1 2026. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Royal Bank of Canada held 780,931 shares of Cardinal Health worth $186M as of Q2 2026.
  • Royal Bank of Canada sold 171,755 Cardinal Health shares in Q2 2026, an estimated $35.7M.
  • Cardinal Health made up 0.03% of Royal Bank of Canada's portfolio in Q2 2026, its #475 holding.
  • Royal Bank of Canada first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • Royal Bank of Canada's Cardinal Health position peaked at $201M in Q1 2026.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.